ABL Bio Market Cap

ABL Bio has a market cap or net worth of 5.1 trillion as of June 12, 2026. Its market cap has increased by 73.72% in one year.

Market Cap

5.10T

Enterprise Value

4.97T

Revenue

90.32B

Ranking

n/a

PE Ratio

n/a

Stock Price

91,100.00

Market Cap Chart

Since December 19, 2018, ABL Bio's market cap has increased from 608.61B to 5.10T, an increase of 738.05%. That is a compound annual growth rate of 32.85%.

Market Cap History

Date	Market Cap	% Change
Jun 12, 2026	5.10T	-53.74%
Dec 30, 2025	11.03T	663.70%
Dec 30, 2024	1.44T	22.53%
Dec 28, 2023	1.18T	7.19%
Dec 29, 2022	1.10T	5.54%
Dec 30, 2021	1.04T	-27.59%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 19, 2018	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	59.95T
Celltrion	38.02T
ALTEOGEN	18.05T
Samsung Epis Holdings	11.11T
HLB Co., Ltd.	6.13T
Sam Chun Dang Pharm.	6.08T
Yuhan	5.76T
Peptron	5.36T

Market Cap Rankings